Table 1 Clinical features data for eight patients with FTPCD
Management | |||||||||
|---|---|---|---|---|---|---|---|---|---|
Patient/sex/age | Involved eye | VA at onset | Leaking site | Sleeping position at onset | Sleeping repositioning | Observation | Treatment | Follow up (months) | VA at outcome |
1/ M/ 7 | OS | 20/20 | Inferior temporal | Nasally down | No | No | Laser + Anti-Vegf | 2 | CF |
2/ F/ 11 | OS | 20/20 | Inferior temporal | Nasally down | No | No | Laser + Anti-Vegf | 6 | CF |
3/M/11 | OS | 20/100 | Temporal | Nasally down | Yes | Yes | Laser + Anti-Vegf | 12 | 20/30 |
4/M/34 | OS | 20/100 | Inferior temporal | Nasally down | Yes | Yes | Ozurdex | 1 | 20/30 |
5/F/62 | OS | 20/150 | Temporal | Nasally down | Yes | Yes | Laser + Ozurdex | 6 | 20/40 |
6/F/39 | OD | 20/60 | Inferior temporal | Nasally down | Yes | Yes | Laser + Anti-Vegf + ST STEROID | 6 | 20/20 |
7/M/27 | OD | 20/20 | Inferior temporal | Nasally down | Yes | Yes | Laser | 3 | 20/20 |
8/M/50 | OE | 20/40 | Inferior temporal | Nasally down | No | No | Laser + Anti-Vegf | 3 | 20/400 |